Kyverna Executives Stack Up Stock: CEO Adds 11,000 Shares, Team Buys 300,000 Options in Bold Confidence Play
Kyverna Therapeutics insider buying shows CEO Andrew Miller and other executives betting on near‑term growth, with fresh options and shares signaling confidence in upcoming milestones.
3 minutes to read